Related Experiment Video
Updated: Nov 26, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Targeting ferroptosis in breast cancer
Zhaoqing Li1,2,3, Lini Chen1,3, Cong Chen1,3
1Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, 310000, Zhejiang, China.
Ferroptosis, a cell death type driven by lipid ROS, is a promising cancer therapy target. This review examines ferroptosis in breast cancer, its regulators, and subtype-specific sensitivities to guide future biomarker and treatment development.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Ferroptosis is a distinct form of regulated cell death.
- It is characterized by the accumulation of lipid-reactive oxygen species (ROS).
- Metabolic pathways and gene expression critically influence ferroptosis, presenting therapeutic opportunities in cancer.
Purpose of the Study:
- To review the current understanding of ferroptosis in breast cancer.
- To trace key ferroptosis regulators historically.
- To discuss ferroptosis sensitivity across breast cancer subtypes.
Main Methods:
- Literature review of ferroptosis studies.
- Comparison of ferroptosis with other regulated cell death mechanisms.
- Analysis of ferroptosis regulators and their historical context.
- Discussion of subtype-specific ferroptosis sensitivity in breast cancer.
Main Results:
- Ferroptosis occurrence is influenced by metabolism and gene expression.
- Different breast cancer subtypes exhibit varying sensitivities to ferroptosis.
- Historical analysis reveals key regulators and their evolution.
Conclusions:
- Understanding ferroptosis's historical context is crucial for breast cancer research.
- Ferroptosis-based biomarkers and therapeutic strategies can be accelerated through this perspective.
- Targeting ferroptosis holds significant potential for managing breast cancer.
More Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...